Jamal El-Mosleh
Chief Executive Officer presso ELICERA THERAPEUTICS AB
Profilo
Mr. Jamal El-Mosleh is a Chief Executive Officer at Elicera Therapeutics AB.
Mr. El-Mosleh was previously employed as a Chief Executive Officer by Annexin Pharmaceuticals AB and a Chief Executive Officer & IR Contact by Immunicum AB.
He also served on the board at Elypta AB.
He received his graduate degree from Chalmers University of Technology and a graduate degree from Chalmers School of Entrepreneurship.
Posizioni attive di Jamal El-Mosleh
Società | Posizione | Inizio |
---|---|---|
ELICERA THERAPEUTICS AB | Chief Executive Officer | 01/01/2020 |
Precedenti posizioni note di Jamal El-Mosleh
Società | Posizione | Fine |
---|---|---|
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | Director/Board Member | 01/01/2020 |
ANNEXIN PHARMACEUTICALS AB | Chief Executive Officer | 01/01/2019 |
MENDUS AB | Chief Executive Officer | 01/10/2016 |
Formazione di Jamal El-Mosleh
Chalmers University of Technology | Graduate Degree |
Chalmers School of Entrepreneurship | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
MENDUS AB | Health Technology |
ANNEXIN PHARMACEUTICALS AB | Health Technology |
ELICERA THERAPEUTICS AB | Health Technology |
Aziende private | 1 |
---|---|
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | Technology Services |
- Borsa valori
- Insiders
- Jamal El-Mosleh